EATL is characterized by strong inflammatory activity, with enriched gene sets like interferon response and IL-6/JAK/STAT3 signaling and overexpressed inflammation-related genes (e.g., PD-L1, CXCL13), suggesting STAT3-driven tumor-promoting inflammation [29, 57–61]. The gene discussed is IL6; the disease is neoplasm.